GE Aerospace reports news on its aircraft engine, services, and systems business, including commercial engine orders, long-term service support, maintenance, repair and overhaul investments, and digital tools used in production, supply chain, and military aircraft readiness. Coverage includes customer selections for GEnx and other GE Aerospace or CFM-powered fleets, dividend declarations, workforce-training initiatives, and governance matters involving defense-related products.
GE Digital has partnered with Alliance Airlines to implement its Fuel Insight™ solution, aiming to enhance fuel efficiency and reduce costs and carbon emissions. This collaboration builds on their existing use of Safety Insight™ and enables Alliance Airlines to leverage data for actionable insights, leading to improved operational efficiency. The airline operates 58 aircraft and plans to add 17 more in 2022, focusing on charter and wet-lease services across Australia. This partnership signifies a strategic move to optimize resources and reduce the airline's CO2 footprint.
GE Digital has launched its Effective Inertia Metering & Forecasting solution for the National Grid ESO, enhancing the management of grid stability amid increasing renewable energy sources. This technology enables real-time measurement of grid inertia, crucial for maintaining operational reliability when generators disconnect. The deployment leverages machine learning and analytics to inform operational decisions and long-term investments, ultimately supporting a greener energy network. The collaboration is part of a staged delivery approach, ensuring adaptive implementation and successful system integration.
GE Current, a Daintree company, has appointed Arctic Sales to represent its LED lighting and controls solutions for DOT and municipality applications in Alaska. Arctic Sales, with over 25 years of experience in lighting, will also manage Hubbell’s C&I Lighting business, following Current's acquisition in February. This partnership aims to provide seamless service in the growing lighting market, leveraging Arctic Sales' knowledge to adapt to evolving technologies. The collaboration seeks to enhance the roadway lighting sector in Alaska, benefiting both companies.
GE Healthcare has received FDA pre-market approval for its End-tidal (Et) Control software, enhancing general anesthesia delivery through precise oxygen and anesthetic agent targets. This software, previously available in Europe since 2010, is now the sole FDA-approved product of its kind in the U.S. It significantly reduces greenhouse gas emissions by up to 44% and operating room costs by 27%, while improving workflow efficiency. Annually, over 300 million surgeries necessitate general anesthesia, costing around $1.2 billion. The software will be available with the Aisys CS2 Anesthesia Delivery System in the coming months.
GE Aviation recently marked a significant milestone by achieving 400 million flight hours and 37 years of on-time delivery for its navigation database (NDB), serving over 14,000 aircraft globally. The NDB, tailored for each customer, includes more than 18,000 airports and offers 24/7 support. GE's advanced flight management systems (FMS) enhance operational efficiency and situational awareness for airlines. This achievement underscores GE's commitment to delivering reliable aviation solutions and continuous advancements in flight management technology.
The U.S. Air Force and GE initiated Phase 2 testing of the XA100 adaptive cycle engine on March 25, 2023, at the Arnold Engineering Development Complex. This engine is significant for the F-35’s future, having completed Phase 1 in November 2021. The XA100 includes innovations that enhance thrust by over 10% and fuel efficiency by 25%, while also being compatible with Sustainable Aviation Fuel. GE Edison Works oversees the development of this ground-breaking engine, which aims to reduce operational costs and ensure enhanced combat capabilities for the F-35.
GE Renewable Energy has unveiled the world's first 420 kV, 63 kA g³ gas-insulated substation (GIS) circuit-breaker prototype. This innovation marks a significant advancement in the power industry, offering a viable alternative to SF6 gas. The g³ technology reduces greenhouse gas emissions by over 99%, contributing to cleaner electrical grids. The prototype, showcased to European transmission utilities, is expected for commercial release in 2023. This move aligns with GE's commitment to accelerating grid decarbonization through innovative solutions.
GE Healthcare has initiated a Phase III clinical trial for a new PET radiopharmaceutical aimed at aiding the evaluation of adult patients with suspected Parkinsonian syndromes. This trial follows the success of DaTscan, a leading SPECT agent, to enhance diagnostic imaging options. The study, taking place in France, compares PET technology's higher resolution against SPECT for better visualization of dopamine transporters. Additionally, a SPECT agent study will begin in the U.S. This expansion supports GE's commitment to improving patient care and aligns with the growing need for Parkinson’s disease diagnostics.
GE Renewable Energy’s Grid Solutions and BOND Civil & Utility Construction have secured an EPC contract from Empire Offshore Wind for the Empire Wind 1 project. This venture will deliver a digital onshore substation and integrate an 816-MW wind power project into the New York Power Grid. Upon completion, it will provide energy to over 500,000 homes in New York and contribute to the state's renewable energy goals, including a 70% generation target by 2030 and a zero-emission electricity sector by 2040.
GE Healthcare has partnered with AliveCor to integrate data from the KardiaMobile 6L personal ECG device into its MUSE cardiac management system. This collaboration enables physicians to access patient ECGs remotely, enhancing diagnostic capabilities and continuity of care. MUSE is already utilized by 87% of the top cardiac hospitals in the U.S. The integration aims to improve patient outcomes by reducing hospitalizations linked to cardiac conditions like atrial fibrillation. The KardiaMobile 6L provides medical-grade ECGs that help physicians monitor heart health conveniently.